C4 Therapeutics Inc. (NASDAQ:CCCC)

Stock Price: $7.96
+0.03 (0.38%)
Updated Nov 28, 2022 03:28 PM GMT+0000
Overview
Financials
Statistics
Profile
Chart
Market Cap 389.70M
Revenue 0
Gross Profit 0
Shares Out 48.96M
EPS (ttm)
PE Ratio 0.0000
Forward PE -3.0854
Dividend Rate (ttm) 0.0000
Dividend Yield 0.0000
Trading Day Nov 28
Last Price $7.96
Previous Close $7.93
Change ($) 0.03
Change (%) 0.38%
Day's Open 7.85
Day's Range 7.85 - 7.96
Day's Volume 77.10K
52 Week Range 4.84 - 38.05

About C4 Therapeutics Inc.

C4 Therapeutics is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer and other diseases. This targeted protein degradation approach offers advantages over traditional therapies, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity.

News

No news found.

Quick info

Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Employees
99
Website
www.c4thera.com
Ticker Symbol
CCCC
Reporting Currency
USD